Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...

Looking forward, IMARC Group expects the 7MM to reach US$ 373.7 Million by 2034, exhibiting a growth rate (CAGR) of 4.63% during 2024-2034. Polymyalgia Rheumatica Market: The 7 major polymyalgia ...

After hours: February 20 at 6:45:26 PM EST Loading Chart for NA ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 29,483.63 Crore) operating in Pharmaceuticals sector. Laurus Labs Ltd. key Products/Revenue Segments ...

Background Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical ...

The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the ...

HealthTech Leeds draws on a community of 150 scientists and clinical academics from across the University of Leeds and Leeds Teaching Hospitals NHS Trust. Professor Hemant Pandit has pursued a career ...